A study on PCOS subjects revealed that 4 week administration of 30 mg/d pioglitazone resulted in reduction in fasting insulin level as well as AUC insulin after 3 months of follow up with no significant changes in BMI and WHR (mean BMI of 28.42 kg/m2) (29). This evidence concerns the gene INS and polycystic ovary syndrome.